Taken together, our data revealed the negative correlation between RPS7 and HIF-1α, and they modulate the glycolysis of colorectal cancer through molecules including GLUT4 and LDHB, which may represent novel prognostic markers and/or therapeutic targets for colorectal cancer. This evidence concerns the gene HIF1A and colorectal cancer.